CDKN1A functions as a tumor suppressor by blocking cell cycle progression via inhibiting CDK1 and CDK2, and CDKN1A-deficiency promotes spontaneous and induced tumors in different tissues [11,43,44,45]. Here, CDK2 is linked to neoplasm.